Newsroom
A Resource for Press and Media
Browse press releases, learn about psoriatic disease, or make a media request.
NPF Newsroom
Press Releases
2023 and 2024
- NPF’s Journal of Psoriasis and Psoriatic Arthritis® Receives PubMed Indexing (October 10, 2024)
- NPF Announces Support of Clinical Registry in Generalized Pustular Psoriasis with Thermo Fisher Scientific’s CorEvitas (September 30, 2024)
- New Research on Phototherapy Published in JAMA Dermatology (September 26, 2024)
- NPF Publishes Comprehensive Psoriasis Health Indicator Report (August 15, 2024)
- Take ACTION for Psoriatic Disease During Psoriasis Action Month (August 1, 2024)
- NPF Welcomes New Board Members (July 29, 2024)
- Research for a Cure: 2024 NPF Grant and Fellowship Awards (July 8, 2024)
- National Psoriasis Foundation Sets the Course for a Cure (July 1, 2024)
- PsA Action Month Launches Today (May 1, 2024)
- NPF Selects Three Youth Ambassador Scholarship Recipients (April 11, 2024)
- The Light Treatment Effectiveness (LITE) Study Reveals Groundbreaking Data on the Effectiveness of Phototherapy (March 9, 2024)
- NPF Honors Extraordinary Medical Professionals for their Dedication to Patient Care at AAD 2024 (March 8, 2024)
- A Year-Round Commitment to Equity (March 5, 2024)
- NPF Celebrates Milestone as Psound Bytes™ Podcast Reaches 200,000 Listens (March 1, 2024)
- The Light Treatment Effectiveness (LITE) Study Demonstrates that Home Phototherapy may be Considered a First Line Treatment Option for Plaque or Guttate Psoriasis (February 22, 2024)
- Copay Assistance Must Count Toward Out-of-Pocket Costs (January 28, 2024)
- The National Psoriasis Foundation Announces Commit to Cure Gala Honorees (January 2024)
- New NPF-Funded Research Suggests that Care Coordination May Substantially Reduce Cardiovascular Risk (December 22, 2023)
- National Psoriasis Foundation Awarded Stellar 4-Star Charity Navigator Rating (October 3, 2023)
- NPF Celebrates 25 Years as Dermatology Resident Education Leader (August 30, 2023)
- Psoriasis Location Affects Quality of Life (August 21, 2023)
- NPF Continues Funding of Novel PsA Diagnostic Grant (August 17, 2023)
- NPF Welcomes 4 New Board Members (July 28, 2023)
- 2023 NPF Grant and Fellowship Awards Announced (July 1, 2023)
- NPF Announces New Rheumatology Fellows Meeting (May 22, 2023)
- NPF Celebrates Safe Step Act Progress – Urges Continued Advancement (May 15, 2023)
- Patient and Provider Groups Applaud Senate Help Committee for Including Safe Step Act in PBM Reform Legislation (May 11, 2023)
- National Psoriasis Foundation Welcomes New Chief Scientific and Medical Officer (May 10, 2023)
- Two of the Nation’s Largest Patient and Provider Advocacy Coalitions Join Forces to Call For Inclusion of Consumer-Friendly Policies in PBM Reform Legislation (April 26, 2023)
- NPF Awards 8 Research Grants and Fellowships (April 19, 2023)
- Patient Advocates and Health Care Provider Groups Applaud Filing of the ‘Safe Step Act’ in U.S. House and Senate (April 13, 2023)
- NPF Honors Extraordinary Medical Professionals (March 17, 2023)
- AAD Remarks from the NPF CEO (March 17, 2023)
- National Psoriasis Foundation Awards 2 Cycle 1 Bridge Grants (February 1, 2023)
- 20 New Products Earn NPF Seal of Recognition (January 19, 2023)
2021 and 2022
- NPF Commit to Cure Gala Honors Dr. Nehal N. Mehta, Dr. Abby S. Van Voorhees, and Sam Lichten (December 12, 2022)
- NPF CEO Elected to National Health Council Board (December 6, 2022)
- NPF Advocates Help 3 States Improve Access to Care (November 11, 2022)
- National Psoriasis Foundation Applauds Key Patient Protections Included in the Inflation Reduction Act (August 12, 2022)
- New Data Shows Americans Overwhelmingly Stressed, Posing a Threat to the 8 Million Living With Psoriasis (August 9, 2022)
- NPF Awards $3.2 Million in Research Grants and Fellowships (July 1, 2022)
- National Psoriasis Foundation Selects Leah M. Howard as President and CEO (June 8, 2022)
- The National Psoriasis Foundation Announces New Chief Financial Officer (April 29, 2022)
- Mary Carroll Appointed to NPF Board of Directors (April 28, 2022)
- Medical Professionals Recognized for their Meaningful Impact on the Psoriatic Disease Community (March 25, 2022)
- National Psoriasis Foundation Partners with National Institutes of Health and Others to Identify and Map Key Biological Pathways That Drive Immune-Mediated and Autoimmune Diseases (December 17, 2021)
- NPF Launches Multimedia Resource Center for Health Care Providers Caring for Individuals with Psoriatic Disease (November 15, 2021)
- Board of Directors Announces Retirement of Long-Serving CEO Randy Beranek, with the National Psoriasis Foundation Positioned for Future Impact (October 1, 2021)
- NPF Announces Funding of Multi-Center Clinical Trial Aimed at Reducing Cardiovascular Risk for the Next Phase of the Psoriasis Prevention Initiative (September 24, 2021)
- North Carolina Becomes Seventh State to Ban Copay Accumulator Adjustment Programs in 2021 (September 22, 2021)
- NPF Presents Alexa B. Kimball, M.D., MPH and Christopher Ritchlin, M.D., MPH with Lifetime Achievement Award (September 9, 2021)
- The National Psoriasis Foundation Announces New Chief Revenue Officer (August 31, 2021)
- The National Psoriasis Foundation Awarded Significant Grant from the Centers for Disease Control and Prevention (August 26, 2021)
- NPF Task Force Issues New Guidance Statements Addressing COVID-19 Vaccine Boosters (August 25, 2021)
- The National Psoriasis Foundation Selects the Happify Health Digital Health Platform, Kopa, As Official Online Community (August 24, 2021)
- NPF Volunteer Family Featured on NBC, Airing Saturday, July 24 (July 24, 2021)
- Step Therapy Reform Becomes Law in Arizona (July 12, 2021)
- National Psoriasis Foundation Awards $2.82 Million in Research Grants and Fellowships (July 2, 2021)
- Oregon Strengthens Utilization Management Protections for Step Therapy and Prior Authorization (June 3, 2021)
- NPF COVID-19 Task Force Issues New Guidance Statements in Response to CDC Guidelines (June 1, 2021)
- NPF COVID-19 Task Force Reinstates Guidance for Johnson & Johnson Vaccine (April 30, 2021)
- NFL Veteran Jonathan Scott Joins NPF Board of Directors (April 26, 2021)
- Nebraska Passes Step Therapy Reform to Improve Patient Protections (April 1, 2021)
- U.S. House and Senate Reintroduce the Safe Step Act (March 30, 2021)
- Medical Professionals Recognized for their Significant Impact on the Psoriatic Disease Community (March 15, 2021)
- NPF COVID-19 Task Force Updates Guidance Statements Regarding COVID-19 Vaccines (March 5, 2021)
- Arkansas Becomes First State to Pass Comprehensive Step Therapy Reform Legislation in 2021 (February 23, 2021)
- Updated Guidance for Management of Psoriatic Disease During the COVID-19 Pandemic Accepted for Publication in the Journal of the American Academy of Dermatology (January 7, 2021)
July 1, 2019 to 2020
- NPF COVID-19 Task Force Issues New Guidance Statements Regarding COVID-19 Vaccines Along with Updates to Prior Guidance (December 14, 2020)
- NPF Announces Opening of 2021 Grant Program (October 15, 2020)
- NPF Announces New Mental Health Grant (October 8, 2020)
- NPF Selects Nine New Youth Ambassadors (September 18, 2020)
- NPF COVID-19 Task Force Guidance for Management of Psoriatic Disease During the Pandemic Accepted for Publication in the Esteemed Journal of the American Academy of Dermatology (September 9, 2020)
- NPF COVID-19 Task Force Provides Guidance for People with Psoriatic Disease (August 19, 2020)
- The National Psoriasis Foundation Names MyPsoriasisTeam as its Official Online Community (August 18, 2020)
- National Psoriasis Foundation Appoints April Armstrong MD as Medical Board Chair (July 16, 2020)
- North Carolina Improves Patient Access Through New Step Therapy Reform Law (July 8, 2020)
- National Psoriasis Foundation Awards $3.28 Million in Research Grants and Fellowships (July 6, 2020)
- National Psoriasis Foundation Celebrates Abby Van Voorhees M.D. (June 26, 2020)
- Louisiana Continues to Protect Patients with Passage of Updated Step Therapy Reform Bill (June 13, 2020)
- Psoriatic Disease Does Not Discriminate (Jun 12, 2020)
- Corrona® Psoriasis Registry Shares Real-World Evidence at AAD Virtual Meeting Experience (June 12, 2020)
- National Psoriasis Foundation Forms COVID-19 Task Force (Jun 11, 2020)
- Medical Professionals Recognized for their Significant Impact on the Psoriatic Disease Community (May 18, 2020)
- 53 Patient and Provider Groups Ask Congress for Step Therapy Guardrails in Future COVID-19 Relief Legislation (April 23, 2020)
- South Dakota Passes New Step Therapy Reform Bill (March 27, 2020)
- National Psoriasis Foundation Releases New Funding Opportunities (November 18, 2019)
- The National Psoriasis Foundation and the American Academy of Dermatology Releases First-Ever Guidelines for Pediatric Psoriasis Treatment (November 5, 2019)
- Senate Introduces Bi-partisan Step Therapy Patient Protections (September 26, 2019)
- Three Experts Join National Psoriasis Foundation Medical Board (August 5, 2019)
- National Psoriasis Foundation Awards $2.8 Million in Research Grants and Fellowships (July 12, 2019)
- New Law Helps Wisconsin Patients Navigate Step Therapy Protocols (July 9, 2019)
- National Psoriasis Foundation to Improve Lives for all with Psoriatic Disease (July 1, 2019)
Request an Interview
Please share details about the media outlet, topic, and deadline for consideration.
About the National Psoriasis Foundation
What we doAbout Psoriasis
Psoriasis and its impactAbout Psoriatic Arthritis
Psoriatic arthritis and its impactJournal of Psoriasis and Psoriatic Arthritis®
Learn about this publicationAdvance Online
Get the latest news and inspirational stories from the psoriasis and psoriatic arthritis community.